{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:50:17Z","timestamp":1792691417871,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T00:00:00Z","timestamp":1638489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013017","name":"Vanderbilt University Medical Center","doi-asserted-by":"publisher","award":["R01 HL 095797-08"],"award-info":[{"award-number":["R01 HL 095797-08"]}],"id":[{"id":"10.13039\/100013017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600249"],"award-info":[{"award-number":["81600249"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870233"],"award-info":[{"award-number":["81870233"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.rmed.2021.106711","type":"journal-article","created":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T12:52:09Z","timestamp":1638535929000},"page":"106711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Differential serum lipid distribution in IPAH and CHD-PAH patients"],"prefix":"10.1016","volume":"191","author":[{"given":"Jingyuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3474-8063","authenticated-orcid":false,"given":"Anandharajan","family":"Rathinasabapathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4904-6635","authenticated-orcid":false,"given":"Jiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2021.106711_bib1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S2213-2600(15)00543-3","article-title":"A global view of pulmonary hypertension","volume":"4","author":"Hoeper","year":"2016","journal-title":"Lancet. Respir. Med."},{"key":"10.1016\/j.rmed.2021.106711_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1513\/AnnalsATS.201508-543OC","article-title":"Prognostic significance of biomarkers in pulmonary arterial hypertension","volume":"13","author":"Al-Naamani","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.rmed.2021.106711_bib3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1378\/chest.12-1246","article-title":"Biomarkers in pulmonary hypertension: what do we know?","volume":"144","author":"Foris","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2021.106711_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ahj.2018.11.001","article-title":"The prognostic value of various biomarkers in adults with pulmonary hypertension; a multi-biomarker approach","volume":"208","author":"Geenen","year":"2019","journal-title":"Am. Heart J."},{"key":"10.1016\/j.rmed.2021.106711_bib5","doi-asserted-by":"crossref","first-page":"D51","DOI":"10.1016\/j.jacc.2013.10.023","article-title":"Pulmonary arterial hypertension: epidemiology and registries","volume":"62","author":"McGoon","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.rmed.2021.106711_bib6","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1017\/S1047951117002591","article-title":"Management of late presentation congenital heart disease","volume":"27","author":"Iyer","year":"2017","journal-title":"Cardiol. Young"},{"key":"10.1016\/j.rmed.2021.106711_bib7","doi-asserted-by":"crossref","first-page":"78s","DOI":"10.1378\/chest.126.1_suppl.78S","article-title":"Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines","volume":"126","author":"McLaughlin","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2021.106711_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.106.630715","article-title":"Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study","volume":"114","author":"Gali\u00e8","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.rmed.2021.106711_bib9","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jacc.2004.02.033","article-title":"Pathologic assessment of vasculopathies in pulmonary hypertension","volume":"43","author":"Pietra","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.rmed.2021.106711_bib10","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1183\/09031936.00030312","article-title":"A potential role for insulin resistance in experimental pulmonary hypertension","volume":"41","author":"West","year":"2013","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2021.106711_bib11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1164\/rccm.201306-1086OC","article-title":"Evidence for right ventricular lipotoxicity in heritable pulmonary arterial hypertension","volume":"189","author":"Hemnes","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2021.106711_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001597","article-title":"Impaired right ventricular hemodynamics indicate preclinical pulmonary hypertension in patients with metabolic syndrome","volume":"4","author":"Gopal","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.rmed.2021.106711_bib13","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/crj.12406","article-title":"Prevalence of metabolic syndrome in patients with pulmonary hypertension","volume":"11","author":"Ussavarungsi","year":"2017","journal-title":"Clinical Respir. J."},{"key":"10.1016\/j.rmed.2021.106711_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1378\/chest.08-2008","article-title":"Association of the metabolic syndrome with pulmonary venous hypertension","volume":"136","author":"Robbins","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2021.106711_bib15","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123611","article-title":"Human PAH is characterized by a pattern of lipid-related insulin resistance","volume":"4","author":"Hemnes","year":"2019","journal-title":"JCI insight"},{"key":"10.1016\/j.rmed.2021.106711_bib16","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1161\/CIRCULATIONAHA.115.019351","article-title":"Fatty acid metabolic defects and right ventricular lipotoxicity in human pulmonary arterial hypertension","volume":"133","author":"Brittain","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.rmed.2021.106711_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20143514","article-title":"HDL cholesterol as a marker of disease severity and prognosis in patients with pulmonary arterial hypertension","volume":"20","author":"Jonas","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.rmed.2021.106711_bib18","first-page":"746","article-title":"Triglyceride-to-High-Density lipoprotein cholesterol ratio and systemic inflammation in patients with idiopathic pulmonary arterial hypertension","volume":"25","author":"Jonas","year":"2019","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res. : Int. med. J. Exp. Clinical Res."},{"key":"10.1016\/j.rmed.2021.106711_bib19","doi-asserted-by":"crossref","first-page":"41650","DOI":"10.1038\/srep41650","article-title":"Low-density lipoprotein cholesterol and survival in pulmonary arterial hypertension","volume":"7","author":"Kopec","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.rmed.2021.106711_bib20","first-page":"683","article-title":"Pulmonary artery pulse wave velocity in idiopathic pulmonary arterial hypertension","volume":"29","author":"Kopec","year":"2013","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.rmed.2021.106711_bib21","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1007\/s12325-020-01304-2","article-title":"Serum high-density lipoprotein cholesterol is significantly associated with the presence and severity of pulmonary arterial hypertension: a retrospective cross-sectional study","volume":"37","author":"Wang","year":"2020","journal-title":"Adv. Ther."},{"key":"10.1016\/j.rmed.2021.106711_bib22","first-page":"1","article-title":"Prognostic value of pulmonary hypertension in pre-dialysis chronic kidney disease patients","author":"Zhang","year":"2020","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.rmed.2021.106711_bib23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/chd.12093","article-title":"Lipoprotein(a) concentrations in adult congenital heart disease patients","volume":"9","author":"Mart\u00ednez-Quintana","year":"2014","journal-title":"Congenit. Heart Dis."},{"key":"10.1016\/j.rmed.2021.106711_bib24","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.metabol.2010.03.014","article-title":"Serum glucose and lipid levels in adult congenital heart disease patients","volume":"59","author":"Mart\u00ednez-Quintana","year":"2010","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.rmed.2021.106711_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ijcp.13378","article-title":"Cardiovascular risk factors and arterial thrombotic events in congenital heart disease patients","volume":"73","author":"Mart\u00ednez-Quintana","year":"2019","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.rmed.2021.106711_bib26","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jpeds.2012.11.073","article-title":"Low total, low-density lipoprotein, high-density lipoprotein, and non-high-density lipoprotein cholesterol levels in patients with complex congenital heart disease after Fontan palliation","volume":"162","author":"Whiteside","year":"2013","journal-title":"J. Pediatr."},{"key":"10.1016\/j.rmed.2021.106711_bib27","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1164\/rccm.201507-1444OC","article-title":"Mechanisms of lipid accumulation in the bone morphogenetic protein receptor type 2 mutant right ventricle","volume":"194","author":"Talati","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2021.106711_bib28","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1513\/AnnalsATS.201608-605OC","article-title":"Abnormal glucose metabolism and high-energy expenditure in idiopathic pulmonary arterial hypertension","volume":"14","author":"Heresi","year":"2017","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.rmed.2021.106711_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123611","article-title":"Human PAH is characterized by a pattern of lipid-related insulin resistance","volume":"4","author":"Hemnes","year":"2019","journal-title":"JCI insight"},{"key":"10.1016\/j.rmed.2021.106711_bib30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.vph.2016.08.009","article-title":"Elevated serum HMGB1 in pulmonary arterial hypertension secondary to congenital heart disease","volume":"85","author":"Huang","year":"2016","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.rmed.2021.106711_bib31","first-page":"7265487","article-title":"Novel molecular mechanisms of pulmonary hypertension: a search for biomarkers and novel drug targets-from bench to bed site","author":"Gajecki","year":"2020","journal-title":"Oxidative Med. Cell longevity"},{"key":"10.1016\/j.rmed.2021.106711_bib32","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1164\/rccm.201001-0007OC","article-title":"Plasma levels of high-density lipoprotein cholesterol and outcomes in pulmonary arterial hypertension","volume":"182","author":"Heresi","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2021.106711_bib33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.amjcard.2012.03.042","article-title":"Serum high-density lipoprotein cholesterol levels as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension","volume":"110","author":"Zhao","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.rmed.2021.106711_bib34","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/thoraxjnl-2018-212144","article-title":"Reduced plasma levels of small HDL particles transporting fibrinolytic proteins in pulmonary arterial hypertension","volume":"74","author":"Harbaum","year":"2019","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2021.106711_bib35","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1182\/blood-2008-03-142604","article-title":"Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease","volume":"113","author":"Yuditskaya","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.rmed.2021.106711_bib36","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/clinchem\/42.4.498","article-title":"Low-density lipoprotein oxidation, antioxidants, and atherosclerosis: a clinical biochemistry perspective","volume":"42","author":"Jialal","year":"1996","journal-title":"Clin. Chem."},{"key":"10.1016\/j.rmed.2021.106711_bib37","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2174\/1566524013363212","article-title":"Lipoprotein cholesterol and atherosclerosis","volume":"1","author":"Kruth","year":"2001","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.rmed.2021.106711_bib38","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.jacc.2003.07.016","article-title":"The relationship between cholesterol and survival in patients with chronic heart failure","volume":"42","author":"Rauchhaus","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.rmed.2021.106711_bib39","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/eurheartj\/ehi195","article-title":"Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy","volume":"27","author":"Christ","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.rmed.2021.106711_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/chf.12006","article-title":"Low-density lipoprotein levels in patients with acute heart failure","volume":"19","author":"Kahn","year":"2013","journal-title":"Congest. Heart Fail."},{"key":"10.1016\/j.rmed.2021.106711_bib41","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/eurheartj\/eht072","article-title":"Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups","volume":"35","author":"Manes","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.rmed.2021.106711_bib42","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jacc.2008.11.025","article-title":"Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension","volume":"53","author":"Beghetti","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.rmed.2021.106711_bib43","doi-asserted-by":"crossref","first-page":"H54","DOI":"10.1093\/eurheartj\/sum019","article-title":"Model of chronic adaptation: right ventricular function in Eisenmenger syndrome","volume":"9","author":"Diller","year":"2007","journal-title":"Eur. Heart J. Suppl."},{"key":"10.1016\/j.rmed.2021.106711_bib44","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/HCO.0b013e3283126954","article-title":"Pulmonary arterial hypertension in adults with congenital heart disease: distinct differences from other causes of pulmonary arterial hypertension and management implications","volume":"23","author":"Dimopoulos","year":"2008","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.rmed.2021.106711_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197700","article-title":"Plasma levels of high density lipoprotein cholesterol and outcomes in chronic thromboembolic pulmonary hypertension","volume":"13","author":"Khirfan","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.rmed.2021.106711_bib46","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/thorax.55.11.934","article-title":"Pulmonary arterial hypertension in patients with sleep apnoea syndrome","volume":"55","author":"Bady","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2021.106711_bib47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11906-018-0899-2","article-title":"Obesity and pulmonary hypertension","volume":"20","author":"Ayinapudi","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.rmed.2021.106711_bib48","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4103\/2045-8932.114756","article-title":"Gender, sex hormones and pulmonary hypertension","volume":"3","author":"Austin","year":"2013","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.rmed.2021.106711_bib49","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","article-title":"Predicting survival in pulmonary arterial hypertension: insights from the Registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL)","volume":"122","author":"Benza","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.rmed.2021.106711_bib50","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/0002-9378(92)91370-P","article-title":"Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins","volume":"166","author":"Crook","year":"1992","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"Suppl","key":"10.1016\/j.rmed.2021.106711_bib51","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1123\/ijsnem.11.s1.s97","article-title":"Plasma triglyceride metabolism in humans and rats during aging and physical inactivity","volume":"11","author":"Hamilton","year":"2001","journal-title":"Int. J. Sport Nutr. Exerc. Metabol."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611121004194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611121004194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:25:50Z","timestamp":1760617550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611121004194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":51,"alternative-id":["S0954611121004194"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2021.106711","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential serum lipid distribution in IPAH and CHD-PAH patients","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2021.106711","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106711"}}